Puma Biotechnology, Inc. (PBYI)
NASDAQ·Healthcare·Biotechnology
$7.55
+0.53%
Mkt Cap $383.61M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Feb 26, 2026 | $68.63M | $59.90M | -12.71% | $0.24 | $0.29 | +20.83% | — | — |
| Q4 2025 Nov 6, 2025 | $68.60M | $54.48M | -20.59% | $0.09 | $0.21 | +133.33% | — | — |
| Q3 2025 Aug 7, 2025 | $51.00M | $52.44M | +2.82% | $0.11 | $0.15 | +36.36% | — | — |
| Q2 2025 May 8, 2025 | $52.75M | $46.01M | -12.78% | $0.02 | $0.10 | +400.00% | — | — |
| Q1 2025 Feb 27, 2025 | $52.50M | $59.08M | +12.53% | $0.10 | $0.43 | +330.00% | — | — |
| Q4 2024 Nov 7, 2024 | $52.50M | $80.54M | +53.41% | $0.35 | $0.41 | +17.14% | — | — |
| Q3 2024 Aug 1, 2024 | $44.70M | $47.08M | +5.33% | -$0.10 | -$0.05 | +50.00% | — | — |
| Q2 2024 May 2, 2024 | $41.05M | $43.77M | +6.62% | -$0.16 | -$0.05 | +68.75% | — | — |
| Q1 2024 Feb 29, 2024 | $73.55M | $72.18M | -1.87% | $0.30 | $0.26 | -13.33% | — | — |
| Q4 2023 Nov 2, 2023 | $73.55M | $56.12M | -23.70% | $0.08 | $0.12 | +50.00% | — | — |
| Q3 2023 Aug 3, 2023 | $51.73M | $54.57M | +5.49% | $0.07 | $0.10 | +42.86% | — | — |
| Q2 2023 May 4, 2023 | $49.63M | $52.77M | +6.34% | $0.04 | $0.09 | +142.85% | — | — |
| Q1 2023 Mar 2, 2023 | $57.06M | $65.70M | +15.14% | $0.06 | -$0.12 | -300.00% | — | — |
| Q4 2022 Nov 3, 2022 | $50.47M | $57.10M | +13.15% | -$0.11 | -$0.01 | +90.91% | — | — |
| Q3 2022 Aug 4, 2022 | $52.62M | $59.52M | +13.10% | $0.00 | $0.21 | +14089.19% | — | — |
| Q2 2022 May 5, 2022 | $45.07M | $45.74M | +1.49% | -$0.13 | -$0.08 | +38.46% | — | — |
| Q1 2022 Mar 3, 2022 | $47.17M | $55.40M | +17.46% | -$0.09 | $0.10 | +211.11% | — | — |
| Q4 2021 Nov 4, 2021 | $55.06M | $46.24M | -16.01% | -$0.23 | -$1.09 | -373.91% | — | — |
| Q3 2021 Aug 5, 2021 | $53.00M | $53.38M | +0.72% | -$0.31 | -$0.13 | +58.06% | — | — |
| Q2 2021 May 6, 2021 | $69.96M | $98.17M | +40.32% | $0.09 | $0.40 | +344.44% | — | — |